Mansouri Leila, Messalmani Mariem, Klai Sarra, Bedoui Ines, Derbali Hajer, Gritli Nasreddine, Mrissa Ridha, Fekih-Mrissa Najiba
Laboratory of Molecular Biology (LM, SK, NG, NF-M), Department of Hematology, Military Hospital, Tunis, Tunisia; and Department of Neurology (MM, IB, HD, RM), Military Hospital, Tunis, Tunisia.
Am J Med Sci. 2015 Apr;349(4):334-7. doi: 10.1097/MAJ.0000000000000416.
BACKGROUND: Alzheimer's disease (AD) is a complex disorder, resulting from an interaction between environmental and genetic factors. Several studies have addressed the association of AD with major histocompatibility complex (MHC) polymorphisms without arriving at any definite conclusions. The human leukocyte antigen (HLA) region is the key susceptibility locus in many immunological diseases. The aim of this study was to investigate the probable association between HLA-DR/DQ alleles and AD in Tunisian patients. METHODS: HLA-DR/DQ genotyping was performed using polymerase chain reaction sequence-specific primers with 55 AD patients and 100 healthy individuals serving as the control group. RESULTS: AD in Tunisian patients was found to be associated with the following alleles (Pc denotes Bonferroni corrected probability values): HLA-DRB115 (Pc < 10-3), DRB104 (Pc = 0.03) and DQB106 (Pc < 10-3). Two haplotypes found to be associated with the disease were DRB11501/DQB10602 (Pc < 10-3) and DRB10402/DQB10302 (Pc = 0.02). CONCLUSIONS: The authors believe this to be the first research linking the haplotypes DRB11501/DQB10602 and DRB104/DQB1*0302 with AD. Larger studies in other populations will be important to support the present findings of the possible susceptible risk of HLA-DR/DQ in AD.
背景:阿尔茨海默病(AD)是一种复杂的疾病,由环境因素和遗传因素相互作用导致。多项研究探讨了AD与主要组织相容性复合体(MHC)多态性之间的关联,但未得出任何明确结论。人类白细胞抗原(HLA)区域是许多免疫性疾病的关键易感位点。本研究的目的是调查突尼斯患者中HLA-DR/DQ等位基因与AD之间可能存在的关联。 方法:采用聚合酶链反应序列特异性引物对55例AD患者和100名健康个体作为对照组进行HLA-DR/DQ基因分型。 结果:发现突尼斯患者的AD与以下等位基因相关(Pc表示经Bonferroni校正的概率值):HLA-DRB115(Pc<10-3)、DRB104(Pc = 0.03)和DQB106(Pc<10-3)。发现与该疾病相关的两种单倍型为DRB11501/DQB10602(Pc<10-3)和DRB10402/DQB10302(Pc = 0.02)。 结论:作者认为这是首次将单倍型DRB11501/DQB10602和DRB104/DQB1*0302与AD联系起来的研究。在其他人群中进行更大规模的研究对于支持目前关于HLA-DR/DQ在AD中可能存在易感风险的研究结果很重要。
Am J Med Sci. 2015-4
Clin Neurol Neurosurg. 2014-6
Transfus Apher Sci. 2013-10
Clin Neurol Neurosurg. 2013-1
Genet Test Mol Biomarkers. 2012-6
Alzheimers Dement. 2024-12
Front Aging Neurosci. 2023-6-21
Genet Epidemiol. 2022-12